Epistaxis (nosebleed) is a common disorder frequently seen in primary care. Most are due to minor damage to nasal mucosa however recurrent or prolonged nosebleeds can be a manifestation of an underlying systemic disorder. The majority can be terminated with simple measures, however, prolonged bleeding may require secondary care intervention. Nosebleeds are not life threatening in most people; however, identification of those at risk from complications is important. Elderly patients and those with underlying bleeding disorders or other co-morbidities require careful assessment and prompt intervention as appropriate to prevent an adverse outcome.
Get full access to this article
View all access options for this article.
References
1.
CartwrightS.MorrisJ.J.PinderD.Managing nosebleeds. Student British Medical Journal (2008) 16: p. 212–14.
2.
GuttmacherA.E.MarchukD.A.WhiteR.I.Hereditary hemorrhagic telangiectasia. New England Journal of Medicine (1995) 333 (14): p. 918–24.
3.
KarpatkinS.Autoimmune thrombocytopenic purpura. Lancet (1997) 349: p. 1531–36.
4.
KucikC.J.ClenneyT.Management of epistaxis. American Family Physician (2005) 71: p. 305–11.
WalkerT.W.MacfarlaneT.V.McGarryG.W.The epidemiology and chronobiology of epistaxis: an investigation of Scottish hospital admissions 1995–2004. Clinical Otolaryngology (2007) 32 (5): p. 361–5.
